General Information of the Compound
Compound ID
CP0458038
Compound Name
N-[2-(furan-2-yl)-[1,2,4]triazolo[1,5-a]quinoxalin-4-yl]acetamide
    Show/Hide
Structure
Formula
C15H11N5O2
Molecular Weight
293.286
Canonical SMILES
CC(=O)Nc1nc2ccccc2n2nc(nc12)-c1ccco1
    Show/Hide
InChI
InChI=1S/C15H11N5O2/c1-9(21)16-14-15-18-13(12-7-4-8-22-12)19-20(15)11-6-3-2-5-10(11)17-14/h2-8H,1H3,(H,16,17,21)
    Show/Hide
InChIKey
UZVPZEVIUXWHEK-UHFFFAOYSA-N
Physicochemical Property
logP
2.4959
Rotatable Bonds
2
Heavy Atom Count
22
Polar Areas
85.32
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44452455
ChEMBL ID
CHEMBL411482
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 112.2 nM
   TI
   LI
   LO
   TS
Protein ID: PT00862, Adenosine receptor A2a
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
Ki = 199.53 nM
   TI
   LI
   LO
   TS
Protein ID: PT01278, Adenosine receptor A2b
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 251.19 nM
   TI
   LI
   LO
   TS
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
Ki = 251.19 nM
   TI
   LI
   LO
   TS